News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Corcept Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Beach
The Day In Review: Amgen Buys Avidia, Inc. For $290 Million
October 3, 2006
·
1 min read
BioCapital
The Week In Review: A Late Summer Bounce For Biotech
September 5, 2006
·
1 min read
Biotech Beach
The Day In Review: Immunicon Corporation Rises On AstraZeneca PLC Deal
August 7, 2006
·
1 min read
Biotech 2005: New Drugs Hold The Key
October 19, 2005
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Overall Survival Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
January 23, 2026
·
7 min read
Press Releases
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
January 1, 2026
·
3 min read
Press Releases
Corcept Therapeutics Announces Third Quarter Financial Results, Oncology Development Programs and Provides Corporate Update
November 4, 2025
·
14 min read
Press Releases
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
October 28, 2025
·
1 min read
Press Releases
Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment
October 19, 2025
·
7 min read
Press Releases
Corcept Submits Marketing Authorization Application to European Medicines Agency for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
October 15, 2025
·
4 min read
Press Releases
Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics
October 2, 2025
·
2 min read
Press Releases
Corcept to Present New Late-Breaking Data From Pivotal ROSELLA Trial of Relacorilant in Platinum-Resistant Ovarian Cancer at ESMO 2025
September 23, 2025
·
4 min read
Press Releases
FDA Files Corcept’s New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
September 11, 2025
·
4 min read
Press Releases
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
July 31, 2025
·
10 min read
